- Home
- SIEB vs OKYO Comparison
SIEB vs OKYO Comparison
Compare SIEB & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SIEB | OKYO |
|---|---|---|
| Founded | 1886 | 2007 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.7M | 81.3M |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SIEB | OKYO |
|---|---|---|
| Price | $1.65 | $1.39 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.33 |
| AVG Volume (30 Days) | ★ 106.9K | 91.3K |
| Earning Date | 05-12-2026 | 07-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $94,202,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 12.28 | N/A |
| 52 Week Low | $1.56 | $1.34 |
| 52 Week High | $4.29 | $3.35 |
Technical Indicators
Market Signals| Indicator | SIEB | OKYO |
|---|---|---|
| Relative Strength Index (RSI) | 44.43 | 39.10 |
| Support Level | $1.56 | N/A |
| Resistance Level | $1.75 | $1.72 |
| Average True Range (ATR) | 0.06 | 0.11 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 64.86 | 15.67 |
Price Performance
Historical ComparisonAbout SIEB Siebert Financial Corp.
Siebert Financial Corp is a diversified financial services firm engaged in providing brokerage and financial advisory services. The coperates through two segments: Financial Services and Media, Sports and Entertainment. The Financial Services segment mainly operates as a securities broker-dealer and provides brokerage, custody, and clearing services for retail accounts, as well as insurance and advisory services, principal and proprietary trading, market making, securities lending, and investment banking and capital markets services. The Media, Sports and Entertainment segment is engaged in the production and distribution of music and media content, as well as talent management and sports representation. It generates the majority of its revenue from the Financial Services segment.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.